Neurology 95 , e1754e1759 (2020)
Overall, several barriers to implementation exist: limited dedicated resources, variability in patients physical conditions, and psychological resistance (e.g., fear of injury, lack of exercise habits)
In our current analysis of the STEP 1 data, we found evidence that semaglutide might lower CVD risk even in populations not enriched for multiple CVD risk factors or with established CVD (primary prevention)
It can feel incredibly tempting to order weight loss injections like Ozempic as they seem to promise fast results, but these medications can be extremely dangerous for those with eating disorders. Quinn said rapid weight loss could contribute to eating disorders developing for the first time in vulnerable people
Ozempic (semaglutide) is a GLP-1 receptor agonist used to help control blood sugar levels in adults with type 2 diabetes